Insider · CIK 0001750094
Matthew Gline
ceoofficerdirector
Files at ROIV (Roivant Sciences Ltd.). First filing Sep 18, 2025, latest Dec 17, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 1
$50k bought, $38M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ROIV: Roivant Sciences Ltd.
ROIVOct 9, 2026 · close 35.44
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Roivant Sciences Ltd. | $38M 1,740,000 shares | -10% | +141% from low-1% from high | |
| 27Weak | ROIVbuy Roivant Sciences Ltd. | $50k 3,315 shares | +0% | +66% from low-1% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -76,171 | $36.57 | $2.8M | 16,583,774 | 10 d ago |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Common Shares | +234,096 | $4.06 | $950k | 17,521,177 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Shares | -230,357 | $21.68 | $5.0M | 17,290,820 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Shares | -3,739 | $21.68 | $81k | 17,287,081 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Common Shares | +1,363,711 | $12.68 | $17M | 18,650,792 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Shares | -566,116 | $21.68 | $12M | 18,084,676 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Shares | -797,595 | $21.68 | $17M | 17,287,081 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Common Shares | +2,272,852 | $12.68 | $29M | 19,559,933 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | SOpen-market sale Common Shares | -943,527 | $21.68 | $20M | 18,616,406 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | JOther Common Shares | -1,329,325 | $21.68 | $29M | 17,287,081 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Stock Option (Right to Buy)derivative | -234,096 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Stock Option (Right to Buy)derivative | -1,363,711 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | MOption exercise Stock Option (Right to Buy)derivative | -2,272,852 | $0.00 | $0 | 0 | Dec 17, 2025 |
| Sep 18, 2025 | ROIV Roivant Sciences Ltd. | POpen-market purchase Common Shares | +3,315 | $15.07 | $50k | 17,287,081 | Sep 18, 2025 |
| May 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $11.04 | $121k | 17,283,766 | May 22, 2025 |
| Apr 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $10.15 | $111k | 17,294,711 | Apr 22, 2025 |
| Mar 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $10.97 | $120k | 17,305,656 | Mar 24, 2025 |
| Feb 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $10.72 | $117k | 17,316,601 | Feb 24, 2025 |
| Jan 20, 2025 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -11,623 | $11.15 | $130k | 17,327,546 | Jan 22, 2025 |
| Dec 20, 2024 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $11.57 | $127k | 17,339,169 | Dec 26, 2024 |
| Nov 20, 2024 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $11.49 | $126k | 17,350,114 | Nov 22, 2024 |
| Oct 20, 2024 | ROIV Roivant Sciences Ltd. | FTax withholding Common Shares | -10,945 | $11.92 | $130k | 17,361,059 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.